Repeated injection at the same site can cause lipohypertrophy (small fatty lumps under the skin) that affect peptide absorption
For many patients, this translates to nausea, particularly in the early weeks of treatment or when doses are increased
By engaging GLP-1 Rs across the gut-brain axis, these agents potentiate physiological satiety signals, slowing gastric emptying, suppressing hunger cues, and diminishing the hedonic appeal of calorie-dense foods
Compounded Tirzepatide Starting at $100.00 1-month supply A weekly GLP-1 injection
PubMed Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition Supports body-composition, lean-mass, and metabolic-risk context
Semaglutide may also impact cortisol levels and stress response systems